enlightenbio was founded in 2013 in the San Francisco Bay Area to provide a conduit between research and related technical and analytical resources. Our company consists of PhD level research scientists who bring decades of industry experience and expertise in the biotechnology, molecular diagnostics, pharma, and life science research markets. We are dedicated to communicating in the researcher’s language, identifying unmet needs, and understanding product development. Our goals are aligned to researcher’s needs to increase experiment productivity and to make sense of the resulting biological data.
In addition to our varied industry experiences – Applied Biosystems (now Thermo Fisher Scientific), DNAnexus, Iconix Biosciences, Incyte, Ingenuity Systems (now a Qiagen company), and Pfizer – we have built and maintained content curation services, defined product strategy, managed tactical product projects, performed extensive ecosystem analyses, and defined go-to-market plans.
Building on our initial success and previous experiences – microarray and next-generation sequence data analysis, toxicogenomics, solutions for sequence data management, analysis, and interpretation, drug discovery, and biochemistry – we continuously monitor worldwide market trends in healthcare information technology, life sciences, genomics, clinical diagnostics, and medical devices space to expand our critical service offerings. Combined with our extensive global network, we can identify target market pain points and unmet needs, preform detailed market and product research, and undertake horizontal and vertical ecosystem or competitive analyses, and more.
This background with our future-focus makes us a resourceful and agile alternative to traditional market research companies. Our comprehensive knowledge of the market we live and breathe is invaluable to our partnerships and potential.
enlightenbio, along with market research reports is managed by Brigitte Ganter, PhD, Founder & Managing Director of enlightenbio LLC.
